CN109010639A - A kind of Chinese medicine composition for treating bronchitis - Google Patents
A kind of Chinese medicine composition for treating bronchitis Download PDFInfo
- Publication number
- CN109010639A CN109010639A CN201811097733.6A CN201811097733A CN109010639A CN 109010639 A CN109010639 A CN 109010639A CN 201811097733 A CN201811097733 A CN 201811097733A CN 109010639 A CN109010639 A CN 109010639A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- root
- chinese medicine
- bronchitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 206010006451 bronchitis Diseases 0.000 title claims abstract description 24
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 210000004072 lung Anatomy 0.000 claims abstract description 13
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 11
- 244000307697 Agrimonia eupatoria Species 0.000 claims abstract description 10
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 10
- 244000157790 Buglossoides arvense Species 0.000 claims abstract description 10
- 235000004256 Buglossoides arvense Nutrition 0.000 claims abstract description 10
- 241000208671 Campanulaceae Species 0.000 claims abstract description 10
- 241000931705 Cicada Species 0.000 claims abstract description 10
- 241000756943 Codonopsis Species 0.000 claims abstract description 10
- 241000123589 Dipsacus Species 0.000 claims abstract description 10
- 244000061508 Eriobotrya japonica Species 0.000 claims abstract description 10
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims abstract description 10
- 241000270288 Gekko Species 0.000 claims abstract description 10
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract description 10
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 10
- 235000013717 Houttuynia Nutrition 0.000 claims abstract description 10
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 10
- 241001598107 Imperata Species 0.000 claims abstract description 10
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 10
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 10
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 10
- 240000000249 Morus alba Species 0.000 claims abstract description 10
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 10
- 241000237502 Ostreidae Species 0.000 claims abstract description 10
- 235000004347 Perilla Nutrition 0.000 claims abstract description 10
- 244000124853 Perilla frutescens Species 0.000 claims abstract description 10
- 241000237636 Pheretima Species 0.000 claims abstract description 10
- 240000002924 Platycladus orientalis Species 0.000 claims abstract description 10
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 10
- 235000000125 common agrimony Nutrition 0.000 claims abstract description 10
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 10
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 10
- 235000020636 oyster Nutrition 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 9
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 9
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 9
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 9
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 9
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 9
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 9
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 9
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 9
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 9
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 9
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 9
- 241000726667 Pegaeophyton Species 0.000 claims abstract description 9
- 241000812653 Gentiana newberryi Species 0.000 claims abstract description 8
- 241001183967 Isodon Species 0.000 claims abstract description 8
- 241001165494 Rhodiola Species 0.000 claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims abstract description 8
- 241000123069 Ocyurus chrysurus Species 0.000 claims description 9
- 244000061520 Angelica archangelica Species 0.000 claims description 8
- 241000246500 Gentianella aspera Species 0.000 claims description 2
- 239000008188 pellet Substances 0.000 claims description 2
- 241000213006 Angelica dahurica Species 0.000 claims 1
- 241000935235 Fritillaria meleagris Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 239000000463 material Substances 0.000 abstract description 7
- 230000000857 drug effect Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical group C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 abstract 2
- 240000002045 Guettarda speciosa Species 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 description 14
- 210000000038 chest Anatomy 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 210000003714 granulocyte Anatomy 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 6
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 6
- 108060003951 Immunoglobulin Proteins 0.000 description 6
- 102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 description 6
- 108010066302 Keratin-19 Proteins 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 6
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 6
- 206010036790 Productive cough Diseases 0.000 description 6
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000003979 eosinophil Anatomy 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 102000018358 immunoglobulin Human genes 0.000 description 6
- 229940099472 immunoglobulin a Drugs 0.000 description 6
- 229940027941 immunoglobulin g Drugs 0.000 description 6
- 229910052698 phosphorus Inorganic materials 0.000 description 6
- 239000011574 phosphorus Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 4
- 238000012827 research and development Methods 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010014561 Emphysema Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 210000003651 basophil Anatomy 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000005713 exacerbation Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- RKFAZBXYICVSKP-AATRIKPKSA-N alpha-asarone Chemical compound COC1=CC(OC)=C(\C=C\C)C=C1OC RKFAZBXYICVSKP-AATRIKPKSA-N 0.000 description 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000012550 audit Methods 0.000 description 1
- 238000002555 auscultation Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 description 1
- 229960004755 ceftriaxone Drugs 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000004565 granule cell Anatomy 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000001709 ictal effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- 208000002815 pulmonary hypertension Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Cell Biology (AREA)
- Insects & Arthropods (AREA)
- Virology (AREA)
- Physiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Marine Sciences & Fisheries (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of Chinese medicine composition for treating bronchitis, it is made of following raw material according to parts by weight: 6-11 parts of mulberry fruit, 1-4 parts of hawthorn, 5-9 parts of gekko, 4-10 parts of campanulaceae, 4-9 parts of radix bupleuri, 3-8 parts of perilla leaf, 5-10 parts of loquat seed, 3-11 parts of root of kirilow rhodiola, 2-6 parts of teasel root, 5-11 parts of lalang grass rhizome, 4-11 parts of semen armeniacae amarae, 5-12 parts of Radix Glycyrrhizae, 3-9 parts of cordate houttuynia, 3-8 parts of hairyvein agrimony, 2-8 parts of Herba Lycopodii, 4-9 parts of bulbus fritillariae cirrhosae, 5-11 parts of herba lysimachiae, 2-6 parts of peach kernel, 5-10 parts of rabdosia lophanthide, 3-9 parts of rhizoma arisaematis, 5-11 parts of the root of Dahurain angelica, 3-8 parts of oyster, 3-9 parts of the seed of Oriental arborvitae, 3-7 parts of peppermint, 3-8 parts of Radix Salviae Miltiorrhizae, 4-10 parts of Radix Codonopsis, 3-6 parts of sea-buckthorn, 2-5 parts of ox lung, 1-3 parts of Asian puccoon, it is alizarin 0.1-0.5 parts careless, 1-4 parts of pheretima, 1-5 parts of cicada slough, 3-10 parts of Bulbus Allii Fistulosi, 1-5 parts of alpine gentian herb and 2-10 parts of acaulescent pegaeophyton herb.The Chinese medicine composition for the treatment of bronchitis of the invention is selected from plurality of Chinese material allocation and forms, and with the synergistic effect between Chinese medicine material, reaches the whole drug effect of composition most preferably, treats bronchitis significant effect.
Description
Technical field
The invention belongs to Chinese medicine research and development technology field, a kind of particularly Chinese medicine composition for treating bronchitis.
Background technique
Bronchitis is the chronic nonspecific inflammation of trachea-bronchial epithelial cell mucous membrane and its surrounding tissue.Clinically with cough,
Expectoration is cardinal symptom, continues 3 months every year, continuous 2 years or 2 years or more.The main reason for it is formed is virus and bacterium
Repeated infection forms bronchial chronic nonspecific inflammation.When mercury dropped, respiratory tract small blood vessel spasm ischemic, defence function
Energy decline etc. is conducive to cause a disease;The chronic stimulations such as smog dust, pollution atmosphere can also fall ill;Smoking becomes bronchial spasm, mucous membrane
Different, ciliary movement reduction, mucilage secretion increase advantageous infectivity;Intolerance factors also have certain relationship.This disease is common in the middle-aged and the old,
With the development of the state of an illness, usually diseases such as concurrent obstructive emphysema, pulmonary hypertension, cor pulmonale, it is serious very
Patient vitals can extremely be jeopardized.
Currently, the Western medicine for treating the disease on medical market commonly uses anti-inflammatory, relievings asthma, expands tracheae medicine, hormone drug without specific drug
Etc. drug therapies, treatment side effect is big, and cannot reach ideal therapeutic effect.
The information disclosed in the background technology section is intended only to increase the understanding to general background of the invention, without answering
When being considered as recognizing or imply that the information constitutes the prior art already known to those of ordinary skill in the art in any form.
Summary of the invention
The purpose of the present invention is to provide a kind of Chinese medicine compositions for treating bronchitis, it can overcome traditional therapy
Deficiency, it is obvious for treating bronchitis effect.
The technical solution provided by the present invention is:
A kind of Chinese medicine composition for treating bronchitis, is made of following raw material according to parts by weight: 6-11 parts of mulberry fruit, mountain
1-4 parts of short, bristly hair or beard, 5-9 parts of gekko, 4-10 parts of campanulaceae, 4-9 parts of radix bupleuri, 3-8 parts of perilla leaf, 5-10 parts of loquat seed, 3-11 parts of root of kirilow rhodiola,
2-6 parts of teasel root, 5-11 parts of lalang grass rhizome, 4-11 parts of semen armeniacae amarae, 5-12 parts of Radix Glycyrrhizae, 3-9 parts of cordate houttuynia, 3-8 parts of hairyvein agrimony, Herba Lycopodii 2-
8 parts, it is 4-9 parts of bulbus fritillariae cirrhosae, 5-11 parts of herba lysimachiae, 2-6 parts of peach kernel, 5-10 parts of rabdosia lophanthide, 3-9 parts of rhizoma arisaematis, 5-11 parts of the root of Dahurain angelica, male
3-8 parts of oyster, 3-9 parts of the seed of Oriental arborvitae, 3-7 parts of peppermint, 3-8 parts of Radix Salviae Miltiorrhizae, 4-10 parts of Radix Codonopsis, 3-6 parts of sea-buckthorn, 2-5 parts of ox lung, Asian puccoon 1-
3 parts, 0.1-0.5 parts of madder, 1-4 parts of pheretima, 1-5 parts of cicada slough, 3-10 parts of Bulbus Allii Fistulosi, 1-5 parts of alpine gentian herb and 2-10 parts of acaulescent pegaeophyton herb.
Preferably, the Chinese medicine composition, is made of following raw material according to parts by weight: 8 parts of mulberry fruit, 2 parts of hawthorn,
6 parts of gekko, 6 parts of campanulaceae, 6 parts of radix bupleuri, 5 parts of perilla leaf, 7 parts of loquat seed, 5 parts of root of kirilow rhodiola, 4 parts of teasel root, 6 parts of lalang grass rhizome, semen armeniacae amarae 7
Part, 8 parts of Radix Glycyrrhizae, 6 parts of cordate houttuynia, 5 parts of hairyvein agrimony, 4 parts of Herba Lycopodii, 5 parts of bulbus fritillariae cirrhosae, 7 parts of herba lysimachiae, 4 parts of peach kernel, rabdosia lophanthide 7
Part, 5 parts of rhizoma arisaematis, 7 parts of the root of Dahurain angelica, 5 parts of oyster, 6 parts of the seed of Oriental arborvitae, 5 parts of peppermint, 5 parts of Radix Salviae Miltiorrhizae, 6 parts of Radix Codonopsis, 4 parts of sea-buckthorn, ox lung 4
Part, 2 parts of Asian puccoon, 0.3 part of madder, 2 parts of pheretima, 3 parts of cicada slough, 5 parts of Bulbus Allii Fistulosi, 3 parts of alpine gentian herb and 4 parts of acaulescent pegaeophyton herb.
Preferably, the Chinese medicine composition, is made of following raw material according to parts by weight:
10 parts of mulberry fruit, 3 parts of hawthorn, 8 parts of gekko, 8 parts of campanulaceae, 7 parts of radix bupleuri, 6 parts of perilla leaf, 7 parts of loquat seed, root of kirilow rhodiola 9
Part, 5 parts of teasel root, 8 parts of lalang grass rhizome, 10 parts of semen armeniacae amarae, 10 parts of Radix Glycyrrhizae, 7 parts of cordate houttuynia, 6 parts of hairyvein agrimony, 4 parts of Herba Lycopodii, bulbus fritillariae cirrhosae 7
Part, 7 parts of herba lysimachiae, 5 parts of peach kernel, 8 parts of rabdosia lophanthide, 6 parts of rhizoma arisaematis, 8 parts of the root of Dahurain angelica, 5 parts of oyster, 6 parts of the seed of Oriental arborvitae, 5 parts of peppermint, pellet
Join 6 parts, 8 parts of Radix Codonopsis, 5 parts of sea-buckthorn, 4 parts of ox lung, 2 parts of Asian puccoon, 0.4 part of madder, 3 parts of pheretima, 4 parts of cicada slough, 8 parts of Bulbus Allii Fistulosi, white flower
3 parts and 8 parts of acaulescent pegaeophyton herb of rough gentian.
Compared with prior art, the invention has the following beneficial effects:
The Chinese medicine composition for the treatment of bronchitis of the invention is selected from plurality of Chinese material allocation and forms, with Chinese medicine material
Between synergistic effect, reach the whole drug effect of composition most preferably, accomplish for the pathogenesis and clinical manifestation of bronchitis
The treatment that internal and external reasons are taken into account focuses on that the internal cause for causing bronchitis has been reached and both treated the symptoms eliminate surface symptoms while
The effect of effecting a permanent cure again.
Specific embodiment
Below with reference to concrete example, the present invention is described in further detail.The Chinese herbal medicine being previously mentioned in embodiment is by pharmacopeia
Provide medicinal part
Embodiment 1:
A kind of Chinese medicine composition for treating bronchitis, is made of following raw material according to parts by weight: 6 parts of mulberry fruit, hawthorn 1
Part, 5 parts of gekko, 4 parts of campanulaceae, 4 parts of radix bupleuri, 3 parts of perilla leaf, 5 parts of loquat seed, 3 parts of root of kirilow rhodiola, 2 parts of teasel root, 5 parts of lalang grass rhizome, bitter apricot
4 parts of benevolence, 5 parts of Radix Glycyrrhizae, 3 parts of cordate houttuynia, 3 parts of hairyvein agrimony, 2 parts of Herba Lycopodii, 4 parts of bulbus fritillariae cirrhosae, 5 parts of herba lysimachiae, 2 parts of peach kernel, small stream are yellow
Careless 5 parts, 3 parts of rhizoma arisaematis, 5 parts of the root of Dahurain angelica, 3 parts of oyster, 3 parts of the seed of Oriental arborvitae, 3 parts of peppermint, 3 parts of Radix Salviae Miltiorrhizae, 4 parts of Radix Codonopsis, 3 parts of sea-buckthorn, ox
2 parts of lung, 1 part of Asian puccoon, 0.1 part of madder, 1 part of pheretima, 1 part of cicada slough, 3 parts of Bulbus Allii Fistulosi, 1 part of alpine gentian herb and 2 parts of acaulescent pegaeophyton herb.
It is crushed or is extracted using above-mentioned Chinese medicine material and be mixed with, tablet or capsule can be made.
Embodiment 2:
A kind of Chinese medicine composition for treating bronchitis, is made of following raw material according to parts by weight: 11 parts of mulberry fruit, hawthorn
4 parts, 9 parts of gekko, 10 parts of campanulaceae, 9 parts of radix bupleuri, 8 parts of perilla leaf, 10 parts of loquat seed, 11 parts of root of kirilow rhodiola, 6 parts of teasel root, lalang grass rhizome 11
Part, 11 parts of semen armeniacae amarae, 12 parts of Radix Glycyrrhizae, 9 parts of cordate houttuynia, 8 parts of hairyvein agrimony, 8 parts of Herba Lycopodii, 9 parts of bulbus fritillariae cirrhosae, 11 parts of herba lysimachiae, peach
6 parts of benevolence, 10 parts of rabdosia lophanthide, 9 parts of rhizoma arisaematis, 11 parts of the root of Dahurain angelica, 8 parts of oyster, 9 parts of the seed of Oriental arborvitae, 7 parts of peppermint, 8 parts of Radix Salviae Miltiorrhizae, Radix Codonopsis 10
Part, 6 parts of sea-buckthorn, 5 parts of ox lung, 3 parts of Asian puccoon, 0.5 part of madder, 4 parts of pheretima, 5 parts of cicada slough, 10 parts of Bulbus Allii Fistulosi, 5 parts of alpine gentian herb and nothing
10 parts of stem mustard.
It is crushed or is extracted using above-mentioned Chinese medicine material and be mixed with, tablet or capsule can be made.
Embodiment 3:
A kind of Chinese medicine composition for treating bronchitis, is made of following raw material according to parts by weight: 9 parts of mulberry fruit, hawthorn 3
Part, 7 parts of gekko, 6 parts of campanulaceae, 7 parts of radix bupleuri, 5 parts of perilla leaf, 8 parts of loquat seed, 9 parts of root of kirilow rhodiola, 3 parts of teasel root, 10 parts of lalang grass rhizome, hardship
7 parts of almond, 10 parts of Radix Glycyrrhizae, 6 parts of cordate houttuynia, 5 parts of hairyvein agrimony, 6 parts of Herba Lycopodii, 7 parts of bulbus fritillariae cirrhosae, 9 parts of herba lysimachiae, 4 parts of peach kernel, small stream
8 parts of yellow grass, 6 parts of rhizoma arisaematis, 9 parts of the root of Dahurain angelica, 5 parts of oyster, 7 parts of the seed of Oriental arborvitae, 5 parts of peppermint, 6 parts of Radix Salviae Miltiorrhizae, 8 parts of Radix Codonopsis, 5 parts of sea-buckthorn,
3 parts of ox lung, 2 parts of Asian puccoon, 0.3 part of madder, 3 parts of pheretima, 2 parts of cicada slough, 8 parts of Bulbus Allii Fistulosi, 4 parts of alpine gentian herb and 8 parts of acaulescent pegaeophyton herb.
It is crushed or is extracted using above-mentioned Chinese medicine material and be mixed with, tablet or capsule can be made.
Embodiment 4: the effect test of Chinese medicine composition of the invention
4.1 case selection
For the effect of the Chinese medicine composition of verifying present invention treatment bronchitis, the bronochitic 300 made a definite diagnosis is selected
Example clinical observation, wherein male 180, women 120, the age 38-75 years old, average age 50 years old, course of disease 1-5, by 300
Patient's stochastic averagina is divided into 3 groups, and group 1, group 2, group 3 are one day three adult respectively using the Chinese materia medica preparation prepared in embodiment 1-3
It is secondary, 5 tablets each time, 2 courses for the treatment of are used continuously.
4.2 efficacy determination
(1) remarkable result: persistent cough, the acutely clinics such as cough and Nausea and vomiting, chest, abdominal muscles pain
The substantially all disappearance of symptom, body substantially restore normal.
(2) effectively: above-mentioned symptom is mitigated, and body is improved.
(3) invalid: without mitigation or to be aggravated by symptom after treatment.
4.3 result
The effect test of the Chinese medicine composition of the invention of table 1
As shown in Table 1, the effective percentage in embodiment 1-3 is 94% or more, it is seen then that Chinese medicine composition of the invention has
Good effect.
Clinical case 1:
Zhang Xijun, male, 62 years old.2017-01-16 physical examination: alkaline phosphatase 256U/L ↑;Immunoglobulin A 8.12g/L ↑;
Immunoglobulin G 27.05g/L ↑;Homocysteine 15.65U/L ↑;11.71 μ g/L of cytokeratin 19 fragment ↑;Neuron
28.65 μ g/L of specificity olefinic alcohol enzyme ↑;5.82 μ g/L of phosphorus shape cell cancer associated antigen ↑;Eosinophil absolute number 1.98
10^9/L↑;22.34 10^9/L of leucocyte;RBC mean hemoglobin concentration 374.00g/L ↑;Large platelet ratio 44.50%
↑;Eosinophil percentage 15.11% ↑;1.23 10^9/L of basophilic granulocyte absolute number ↑;High-density lipoprotein gallbladder is solid
Alcohol 0.82mmol/L ↓;Percentage of lymphocyte 50.60% ↑;Platelet distribution width 19.40fL ↑;Low density lipoprotein cholesterol
5.08mmol/L↑.2017-05-20 physical examination: alkaline phosphatase 186U/L ↑;Immunoglobulin A 5.12g/L ↑;Immunoglobulin G
17.05g/L↑;Immunoglobulin M 3.05g/L ↑;7.21 μ g/L of cytokeratin 19 fragment ↑;Neuronspecific enolase
18.35μg/L↑;3.2 μ g/L of phosphorus shape cell cancer associated antigen ↑;13.40 10^9/L of leucocyte;RBC mean hemoglobin concentration
354.06g/L↑;Eosinophil percentage 10.11% ↑;1.02 10^9/L of basophilic granulocyte absolute number ↑.
Repeated coughing before patient one month, be short, stemness pain cough, and night (early morning) or movement after it is particularly evident plus
Weight, eats common cold cough drug effect fruit and is not obvious.In the case where not knowing that the cause of disease takes medicine invalid again, patient has carried out body
Physical examination is looked into, as a result, it has been found that leucocyte and other index of correlation are also obvious higher.Then start to take one kind of the research and development of my company
The Chinese medicinal formulae for preventing bronchitis is checked after taking four months, is absolutely not panted, is coughed, going upstairs has strength.Suffer from
The mental status of person is good, energetic.
Clinical case 2:
Zeng Hua, male, 78 years old.Because " repeated coughing, expectoration 36 years aggravated 7 days with 5 years out of breath " is admitted to hospital in 2012-03-01 "
Past medical history: previously having " cerebral infarction " medical history 15 years, has " coronary heart disease " history 10 years, denies hypertension, rheumatic heart disease, diabetes medical history,
Without the infectious diseases medical history such as hepatitis, tuberculosis, the allergies such as no food, drug, no operation, significant trauma history, no blood transfusion history, prevention connect
Kind is carried out with society;Personal history: birth is local, no Infested- water contact history, the special hobby such as no tobacco and wine, at loose ends medical history;Family history:
Free from infection contact history in family can be ask without heredity medication history." present illness history: often there is cough in front of 20 years after suffering from cold in patient
It coughs, expectoration, phlegm is white foam sample, is broken out 2-3 times when being more than Winter-Spring cold, breaks out continue 1-2 months or so every time, voluntarily mouth
It can improve after taking anti-inflammatory drug (specifically unknown), not give enough attention.Cough, expectoration gradually aggravate in five years ago, and annual breaking-out is held
2 months or more continuous, sooner or later outstanding acute, amount of expectoration is more, is white foam sample, is sometimes yellow purulent sputum, and stair climbing, stem body gradually occur
Shortness of breath whens power work etc., but daily life is still taken care of oneself.Once it is medical repeatedly to come the court, is diagnosed as " chronic bronchitis, pulmonary emphysema ",
Symptom gradually improves after the treatment such as anti-inflammatory is given in outpatient service or hospitalization.Aggravation of coughing after suffering from cold was acted before 7 days, amount of expectoration increases, for white
Purulent sputum glues and is not easy expectoration, out of breath to aggravate earlier above, voluntarily takes orally " Brown Mixtura " etc. and comes the court in vain and go to a doctor, outpatient service
It is diagnosed as " chronic bronchitis, pulmonary emphysema " and takes in and be hospitalized.Without pectoralgia, no night sweat, hemoptysis, no weight loss, nothing in the course of disease
Double lower limb oedema, stomach receive night and sleep not good enough, and two is just normal." admission examination: 36.8 DEG C of P of T, 80 points of R, 25 beats/min of Bp128/
70mmHg development is normal, and nutrition is medium, and mind is clear, takes semireclining position, physical examination cooperation.Whole skin mucous membrane has no xanthochromia, fash, goes out
Blood point, superficial lymph knot do not touch enlargement.Head is without deformity.Eyelid is without edema, bulbar conjunctiva Mild edema, and sclera is without xanthochromia, and two
The circle such as side isocoria reflects light sensitive.Ear is without deformity, no purulent secretion.For nose without deformity, ventilation is good.Lip cyanosis,
Oral mucosa swallows not congested, tonsillotome not enlargement without ulcer.Neck is symmetrical, and neck is soft, and jugular vein is without anger, hepatojugular reflux
Sign is negative.Tracheae is placed in the middle, thyroid gland not enlargement.Emphysematous chest, bilateral intercostal space is broadening, and bilateral breathing campaign is symmetrical, weakens, the rhythm and pace of moving things
Rule.Two sides vocal fremitus is symmetrical, weakens, and does not touch sense of pleural friction, subcutaneous crepitus.Two lung percussions are in hyperresonant note.Two pulmonary respiration
Sound weakens, and egressive extends, two lung top audibles and dry rale, two base of lung audibles and fine moist rale.Pareordia is without protuberance, the heart
Point beating is not touched and is trembled, border of cardiac dullness percussion is unclear in normal range (NR).It 80 beats/min of heart rate, restrains and owes neat, audible and premature beat,
Heart sound is remote, and each valve area is not heard and pathologic murmur.Abdomen is flat, and abdomen is soft, no tenderness, rebound tenderness, does not touch under liver and spleen rib,
The liver upper bound the 6th intercostal on right midclavicular line, without percussion pain, shifting dullness is negative in the area Gan Shen, and 5 beats/min of gurgling sound.Backbone
And four limbs are normal without deformity, activity, joint is without red and swollen, tenderness, and double lower limb is without oedema.Abdominal reflexes, the bicipital muscle of arm, the upper arm three
Flesh, knee jerk, Achilles jerk are normal, and babinski's sign, meningeal irritation sign are negative."
The state of an illness of patient has continued more than 30 years, and as the age is increasing, the state of an illness has the phenomenon that exacerbation, therapeutic effect instead
It is less obvious.Recognize the research and development of my company it is a kind of prevent the Chinese materia medica preparation of bronchitis after, started to take in 2 months 2014
With taking not timing after a period of time and check, discovery indices have different degrees of improvement, and patient also illustrates that whole
It is personal all easily a lot of, as stair climbing is no longer felt to pant;Also some outdoor activities can suitably be carried out;Sleep also obtains at night
Very big improvement etc., the state of mind of people is good day by day, and energy is also brought up.
Clinical case 3:
Li Lin, male, 62 years old.Patient is admitted to hospital because of " asthma uncomfortable in chest two months aggravates one week with cough and expectoration ".Patient two months
Before start asthma uncomfortable in chest occur, aggravated after activity, with paroxysmal cough, expectoration, phlegm is the glutinous phlegm of white, measures more, can be brought up, nothing
Fever, night sweat, no pectoralgia, hemoptysis, no headache, Nausea and vomiting;Unconscious obstacle;Without abdominal pain diarrhea;Without frequent micturition, urgent urination, not
Medical treatment, cannot alleviate after rest, and nearly two weeks symptoms obviously aggravate, without syntexis since morbidity, diet can, night can lie down into
It sleeps, there is dreaminess.[past medical history] is previously long-term to smoke, and 30 daily, drinks about two liang daily, there is chronic cough's expectoration.Deny being preced with
Heart trouble, hypertension, diabetes, hepatitis pulmonary tuberculosis etc., no surgery trauma history and blood transfusion history." [physical examination] mind is clear, steps into disease
Room, lip, face and the obvious cyanosis of palm, double lower lungs can and obvious bubble, heart rate 100bpm, rule is neat, and not and pathologic is miscellaneous
Sound, abdomen (-) double lower limb pneumonedema, nervous system (-) " " [auxiliary examination] oxygen and 57%, 80% or so after oxygen uptake, blood routine: in
Property 90%, vim and vigour ph 7.312Pco 288mmhg;Biochemistry analysis+tuberculosis antibody+RF+ASO+ five indexes of hepatitis b+first c-hepatitis antibody+
Tumor marker (-) heart infarction three, D dimer are normal, UCG: Impaired Cardiac Diastolic Function, EF66%, pulmonary arterial pressure
69mmHG, two enhanced lung markings of chest CT, has no occupy-place and inflammatory lesions."
Patient's long-term smoking and every staggering amount is relatively more never takes feasible arrange so eating for a long time with cough cough
It applies, is hospitalized for treatment after aggravation, and start to take a kind of food for preventing bronchitis of the research and development of my company, take one
After the section time, the patient feels are good, and cough cough, which is eaten, to be significantly reduced, and asthma symptom uncomfortable in chest disappears, reinspection result and progress before
Comparison discovery indices have different degrees of improvement and some indexes reach standard, and entire people is obviously in light shape
State, energy are become better and better!
Clinical case 4:
Li Shiwen, male, 62 years old." cough, asthma, have within expectoration 15 years it is more, with 5 years out of breath, exacerbation 7 days, 2013-08-23 enters
In Dongguan the People's Hospital." past medical history: previously have " coronary heart disease " medical history 16 years, " old-slow-bronchial tube " asthma history 16 years, deny hypertension,
Rheumatic heart disease, diabetes medical history, the infectious diseases medical history such as no hepatitis, tuberculosis, the allergies such as no food, drug, no operation, significant trauma
History, no blood transfusion history, immunization campaign are carried out with society;Personal history: birth is local, no Infested- water contact history, the special hobby such as no tobacco and wine,
At loose ends medical history;Family history: free from infection contact history in family can be ask without heredity medication history.Tentative diagnosis: chronic bronchitis is anxious
Property breaking-out;Chronic obstructive emphysema;Coronary atherosclerotic heart disease;Ischemic cardiomyopathy;Ⅲcardiac function;Cerebral infarction
Plug.2015-04-16 physical examination: alkaline phosphatase 196U/L ↑;Glucose 4.62mmol/L;Immunoglobulin A 7.42g/L ↑;It is immune
Lysozyme 24.05g/L ↑;1 7.45g/L of immunoglobulin M ↑;18.01 μ g/L of cytokeratin 19 fragment ↑;Neuron-specific
27.86 μ g/L of property enolase ↑;8.90 μ g/L of phosphorus shape cell cancer associated antigen ↑;22.34 10^9/L of leucocyte;Acidophil granules
Cell absolute number 1.9810^9/L ↑;Eosinophil percentage 15.11% ↑;Basophilic granulocyte absolute number 1.2310^9/L
↑;Basophilic granulocyte percentage 2.38% ↑.
2017-09-16 physical examination: alkaline phosphatase 124U/L;Immunoglobulin A 4.92g/L ↑;Immunoglobulin G
10.80g/L;Immunoglobulin M 3.01g/L ↑;3.71 μ g/L of cytokeratin 19 fragment;Neuronspecific enolase
19.03μg/L↑;1.45 μ g/L of phosphorus shape cell cancer associated antigen;8.87 10^9/L of leucocyte;Eosinophil absolute number
0.4910^9/L;0.056 10^9/L of basophilic granulocyte absolute number;Basophilic granulocyte percentage 0.98% ↑.
The state of an illness of patient has continued 16 years, and as the age is increasing, the state of an illness has the phenomenon that exacerbation instead, and therapeutic effect is not
It is too obvious.Recognize the research and development of my company it is a kind of prevent the Chinese materia medica preparation of bronchitis after, start to take in May, 2015
With taking not timing after a period of time and check, discovery indices have different degrees of improvement, and patient also illustrates that whole
It is personal all easily a lot of, as stair climbing is no longer felt to pant;Also some outdoor activities can suitably be carried out;Sleep also obtains at night
Very big improvement etc., the state of mind of people is good day by day, and energy is also brought up.
Clinical case 5:
Zou Xi, female, 55 years old." patient previously has chronic bronchitis more than ten years, whenever winter-spring season cough and asthma aggravates.Four days
Preceding patient consciously has a stuffy nose, runny nose cough, dizzy out of strength, and gradually row aggravates the state of an illness, and cough and asthma, phlegm matter Huang is thick, measures medium, no trace of blood,
In the course of disease, no fever, shortness of breath is uncomfortable in chest, palpitaition, receives difference, and pulmonary emphysema sign, mainly centrilobular type pulmonary emphysema, stool and urine is just
Often." CT scan, it is seen that tracheae caliber further becomes smaller, the calcification or ossification of tracheal wall, no tube wall thickening.
Patient violates more than 10 years chronic bronchitis, especially aggravates whenever season exchanges the period state of an illness, especially spring and autumn
Time.By understanding, in conjunction with the practical state of an illness, a kind of of research and development that patient starts to take in July, 2015 my company prevents branch gas
The Chinese materia medica preparation of Guan Yan is checked after taking 3 months, with before compare discovery indices have it is different degrees of
Improve, when the September part in this year is checked, discovery indices tend to designation number, patient also illustrate that cough and asthma, shortness of breath,
These symptoms such as palpitaition are fewer and fewer repeatedly, and entire people is obviously in light state, and energy is become better and better!
Clinical case 6:
Li Jianjie, male, 47 years old.Main suit: cough, expectoration 3 days aggravate 1 day.Present illness history: there is cough after suffering from cold before 3 days in patient
It coughs, expectoration, is in paroxysmal, be very expectoration white mucus phlegm with night, no fever is dizzy, uncomfortable in chest, pectoralgia.From the medicine does no good to
(specifically taking medicine unknown) symptom is without being clearly better, and symptom is further aggravated over 1 day, and cough, expectoration break out in duration, and expectoration is viscous
The thick dense phlegm of Huang, is not easy expectoration, and spiritual appetite is fine since onset, and stool and urine is normal, and weight is without substantially changeing."
Physical examination: T36.5 DEG C;75 beats/min of P;18 beats/min of R;BP120/75mmHg.Development is normal, and nutrition is medium,
Sanity, breathing is smooth, active posture, physical examination cooperation.Whole skin, sclera are without xanthochromia, no blutpunkte, no liver palms and spider
Mole.Superficial lymph knot is not laid one's hand on and enlargement.Head face reflect spirit to light without deformity, no facial paralysis sign, the circle such as bilateral isocoria
Quick, external auditory canal secretion without exception overflows, and the wing of nose is without instigating, and lip is without cyanosis, and pharynx is slightly congested, and tonsillotome is without enlargement.Jugular vein without
Full, tracheae is placed in the middle, and thyroid gland is not laid one's hand on and enlargement, and neck is soft, passivity.Bilateral respiratory movement is symmetrical, no sense of pleural friction, double lungs
Breath sound is thick, audible and a small amount of moist rales.Pareordia is located at 0.5 in the 5th intercostal linea medioclavicularis of left side without protuberance, apex beat
Centimeters, heart circle is normal, and 75 beats/min of heart rate, rule is neat, and no noise, each auscultatory valve areas is not heard and pathologic murmur.Xiphoid-process is without pressure
Bitterly, abdomen is flat has no that gastrointestinal type and peristaltic wave, vena epigastrica have no varicose, and abdomen is soft, no tenderness and rebound tenderness, do not laid one's hand under liver and spleen rib and
Mass, liver, kidney area are without pain is kowtowed, and shifting dullness is negative, and gurgling sound is normal.Anus and external genital organs are not looked into, and backbone, four limbs are without abnormal
Shape, activity freely, double lower limb pneumonedema.Four limbs muscular strength, Muscle tensility are normal, and pathology sign is not drawn, and meningeal irritation sign is negative.
2017-9-16 physical examination: alkaline phosphatase 136U/L ↑;Immunoglobulin A 5.92g/L ↑;Immunoglobulin G
17.85g/L↑;Immunoglobulin M 3.01g/L ↑;5.71 μ g/L of cytokeratin 19 fragment ↑;Neuronspecific enolase
19.03μg/L↑;1.82 μ g/L of phosphorus shape cell cancer associated antigen ↑;13.87 10^9/L of leucocyte;Eosinophil absolute number
0.97 10^9/L↑;0.18 10^9/L of basophilic granulocyte absolute number ↑;Basophilic granulocyte percentage 1.08% ↑.
Patient has the phenomenon that exacerbation because voluntarily taking medicine without the state of an illness is improved instead.It can be seen that patient's from audit report
Leucocyte and other index of correlation are obviously higher.Belong to anxious hair property tracheitis, the one kind for then starting the research and development for taking my company is pre-
The Chinese materia medica preparation of anti-bronchitis, this period taken, patient are clearly felt that nasal obstruction, discomfort, sore-throat and violent cough
The symptoms such as the appearance coughed are reduced, and mental status is also become better and better.
Clinical case 7:
Chen Huian, male, 48 years old.Main suit: being engaged in finishing more than 20 years of work, without special in family.Patient was frequent before 4 years
Acutely cough, expectoration (white foam sample), cough property are paroxysmal, ictal, and the duration differs in length, when coughing serious
With shortness of breath uncomfortable in chest, lies down, aggravated after heavy meal of bending over.Medical treatment many places diagnosis and treatment at that time (specifically unknown) less effective, it is annual to break out
Two or three times, continue 2 months after breaking-out every time or more long, not because being gradually cured.7 rain before it after impunity drink with friend after send out again
Disease, cough, expectoration is more violent, and the duration is longer.With the medical commune hospital of shortness of breath uncomfortable in chest, on inspection x-ray prompt when breaking-out
Tracheitis gives ceftriaxone, asarone, and aminophylline treats 5 days without alleviation, and antibiotic is changed to patient's self-induction chest after Archie before two days
Bored exacerbation after drug withdrawal and has the feeling of mitigation voluntarily to leave hospital, and symptom remains unchanged to examine after going home.Diet is looked into since idiopathy, sleep
Still, just increase phenomenon, no chilly fever, no night with uncomfortable in chest, headache, sore-throat, stomach wall pain and two when coughing fit
Night sweat, without heartburn etc..
2015-02-10 physical examination: alkaline phosphatase 276U/L ↑;Immunoglobulin A 9.92g/L ↑;Immunoglobulin G
26.75g/L↑;Immunoglobulin M 5.98g/L ↑;8.21 μ g/L of cytokeratin 19 fragment ↑;Neuronspecific enolase
26.53μg/L↑;5.28 μ g/L of phosphorus shape cell cancer associated antigen ↑;26.81 10^9/L of leucocyte;Eosinophil absolute number
1.97 10^9/L↑;1.18 10^9/L of basophilic granulocyte absolute number ↑;Basophilic granulocyte percentage 3.08% ↑.
2017-10-20 physical examination: alkaline phosphatase 130U/L ↑;Immunoglobulin A 4.02g/L ↑;Immunoglobulin G
15.05g/L;Immunoglobulin M 2.25g/L;3.87 μ g/L of cytokeratin 19 fragment;Neuronspecific enolase
15.56μg/L;1.21 μ g/L of phosphorus shape cell cancer associated antigen;8.97 10^9/L of leucocyte;RBC mean hemoglobin concentration
355.16g/L↑;Eosinophil percentage 7.81%;Basophilic granulocyte absolute number 0.0510^9/L.
The finishing occupation of patient has certain pollution condition, and patient's but effect of seeing a doctor since uncomfortable is less obvious,
There is no much improvement for the state of an illness, and a kind of of research and development for then starting to take my company after last time is medical prevents bronchitis
Chinese materia medica preparation, just increase after taking 2 years, when patient's coughing fit with uncomfortable in chest, headache, sore-throat, stomach wall pain and two existing
As having disappeared, on inspection, every index of patient improves, and some indexes have reached typical coefficient, and the state of mind is also more next
It is better, it is energetic.
Clinical case 8:
Zhang Jiansheng, male, 37 years old.Main suit: cough, expectoration 3 months.
: there is cough, expectoration in present illness history after suffering from cold before patient 3, is in paroxysmal, is very expectoration white mucus with night
Phlegm, no fever is dizzy, uncomfortable in chest, pectoralgia.From the medicine does no good to (specifically taking medicine unknown), symptom without being clearly better, carried out disease before two weeks
Shape is further aggravated, and cough, expectoration break out in duration, and the sticky dense phlegm of Huang of expectoration is not easy expectoration, and spirit appetite is still since onset
Can, stool and urine is normal, and weight is without substantially changeing.
2016-06-16 physical examination: alkaline phosphatase 216U/L ↑;Immunoglobulin A 8.92g/L ↑;Immunoglobulin G
28.85g/L↑;Immunoglobulin M 5.01g/L ↑;9.71 μ g/L of cytokeratin 19 fragment ↑;Neuronspecific enolase
22.03μg/L↑;3.82 μ g/L of phosphorus shape cell cancer associated antigen ↑;20.87 10^9/L of leucocyte;Eosinophil absolute number
1.97 10^9/L↑;1.18 10^9/L of basophilic granulocyte absolute number ↑;Basophilic granulocyte percentage 3.08% ↑.
2017-10-20 physical examination: alkaline phosphatase 126U/L ↑;Immunoglobulin A 4.12g/L ↑;Immunoglobulin G
16.05g/L↑;Immunoglobulin M 2.05g/L;4.21 μ g/L of cytokeratin 19 fragment;Neuronspecific enolase
16.35μg/L↑;1.82 μ g/L of phosphorus shape cell cancer associated antigen ↑;9.40 10^9/L of leucocyte;RBC mean hemoglobin concentration
354.06g/L↑;Eosinophil percentage 7.11%;0.06 10^9/L of basophilic granulocyte absolute number ↑.
It can be appreciated that patient voluntarily takes medicine because uncomfortable but has no the improvement state of an illness, instead from the physical examination of patient report
And there is the phenomenon that exacerbation.Leucocyte and other index of correlation are obviously higher, and patient frequently experiences nasal obstruction, has sore throat and cough
Deng feeling general weakness when sometimes can also acutely cough, a kind of of research and development for then starting to take my company prevents bronchus
Scorching Chinese materia medica preparation, after taking a period of time, patient is clearly felt that nasal obstruction, discomfort, sore-throat and the appearance acutely coughed
Etc. symptoms reduce, the state of mind is also become better and better, and can suitably carry out outdoor activities.
Clinical case 9:
Zhang Di, male, 64 years old.2015-02-06 physical examination: alkaline phosphatase 245U/L ↑;Immunoglobulin A 9.02g/L ↑;Exempt from
Epidemic disease Lysozyme 28.35g/L ↑;10.71 μ g/L of homocysteine 14.55U/L ↑ cytokeratin 19 fragment ↑;Neuron is special
29.35 μ g/L of specific enolase ↑;6.72 μ g/L of phosphorus shape cell cancer associated antigen ↑;2.18 10^ of eosinophil absolute number
9/L↑;22.14 10^9/L of leucocyte;RBC mean hemoglobin concentration 381.00g/L ↑;Large platelet ratio 45.50% ↑;It is thermophilic
Eosinophil percentage 15.15% ↑;1.33 10^9/L of basophilic granulocyte absolute number ↑;High-density lipoprotein cholesterol
0.65mmol/L↓;Percentage of lymphocyte 52.10% ↑;Platelet distribution width 20.40fL ↑;Low density lipoprotein cholesterol
6.02mmol/L↑。
2017-01-20 physical examination: alkaline phosphatase 176U/L ↑;Immunoglobulin A 4.98g/L ↑;Immunoglobulin G
16.25g/L↑;Immunoglobulin M 3.03g/L ↑;6.29 μ g/L of cytokeratin 19 fragment;Neuronspecific enolase
17.87μg/L↑;2.8 μ g/L of phosphorus shape cell cancer associated antigen;13.41 10^9/L of leucocyte;RBC mean hemoglobin concentration
344.66g/L↑;Eosinophil percentage 9.15% ↑;1.12 10^9/L of basophilic granulocyte absolute number ↑.
Patient's cough, expectoration, sometimes with wheezing, every annual meeting is fallen ill 3 months, and continuous 2 years, effect of taking medicine was not obvious, disease
There is no much improvement for feelings, and a kind of of research and development for then starting to take my company after removing hospital admission prevents in bronchitis
Medicine preparation, after taking 2 years, when patient's coughing fit, has disappeared with illnesss such as uncomfortable in chest, headache, sore-throats.Hospital on inspection
Afterwards, every index of patient improves, some indexes substantially reduce even up to designation number, and the state of mind is also become better and better,
It is energetic and can suitably carry out outdoor activities.
Clinical case 10:
Wang Zijian, male, 48 years old.: there is phlegm in main suit in private prosecution pipeline, from difficult expectoration.Personal history: deny that cigarette, wine etc. are bad thermophilic
It is good, deny Infested- water contact history, working environment can.
2015-03-04 physical examination: alkaline phosphatase 287U/L ↑;Immunoglobulin alpha 1 0.02g/L ↑;Immunoglobulin G
27.35g/L↑;Immunoglobulin M 6.18g/L ↑;8.87 μ g/L of cytokeratin 19 fragment ↑;Neuronspecific enolase
28.23μg/L↑;6.08 μ g/L of phosphorus shape cell cancer associated antigen ↑;26.41 10^9/L of leucocyte;Eosinophil absolute number
2.07 10^9/L↑;1.32 10^9/L of basophilic granulocyte absolute number ↑;Basophilic granulocyte percentage 4.12% ↑.
2017-12-13 physical examination: alkaline phosphatase 128U/L ↑;Immunoglobulin A 4.32g/L ↑;Immunoglobulin G
15.01g/L;Immunoglobulin M 1.85g/L;4.17 μ g/L of cytokeratin 19 fragment;Neuronspecific enolase
16.02μg/L;1.25 μ g/L of phosphorus shape cell cancer associated antigen;9.17 10^9/L of leucocyte;RBC mean hemoglobin concentration
365.03g/L↑;Eosinophil percentage 7.81%;Basophilic granulocyte absolute number 0.1810^9/L.
It can be appreciated that patient sees a doctor since uncomfortable, but effect is less obvious from the physical examination of patient report, disease
There is no much improvement for feelings, then start a kind of Chinese materia medica preparation for preventing bronchitis for the research and development for taking my company, take one
After the section time, phlegm in patient conduit can expectoration easily, breathe also smooth very much.And on inspection, every index of patient
It improves, and some indexes have reached typical coefficient, mental status is become better and better, and physical fitness is improving.
Clinical case 11:
Korea Spro steps on, male, and 60 years old.Private prosecution: cough, expectoration 4 months, asthma breathe relatively difficult.[past medical history] denies lung purulence
It is swollen, coronary heart disease, hypertension, diabetes, hepatitis pulmonary tuberculosis etc., no surgery trauma history and blood transfusion history.
2015-08-10 physical examination: alkaline phosphatase 403U/L ↑;Immunoglobulin A 7.82g/L ↑;Hemoglobin 112g/L ↓,
Immunoglobulin G 21.65g/L ↑;Immunoglobulin M 8.45g/L ↑;9.98 μ g/L of cytokeratin 19 fragment ↑;Neuron is special
27.15 μ g/L of specific enolase ↑;7.76 μ g/L of phosphorus shape cell cancer associated antigen ↑;Leucocyte 23.0410^9/L;Acidophil granules
2.95 10^9/L of cell absolute number ↑;Eosinophil percentage 14.69% ↑;1.76 10^ of basophilic granulocyte absolute number
9/L↑;Basophilic granulocyte percentage 3.01% ↑.
2017-11-08 physical examination: alkaline phosphatase 122U/L;Immunoglobulin A 3.72g/L ↑;Immunoglobulin G
15.72g/L↑;Immunoglobulin M 2.18g/L;3.98 μ g/L of cytokeratin 19 fragment ↑;Neuronspecific enolase
16.45μg/L↑;1.62 μ g/L of phosphorus shape cell cancer associated antigen ↑;8.97 10^9/L of leucocyte;Eosinophil absolute number
0.53 10^9/L↑;Eosinophil percentage 7.72% ↑;0.04 10^9/L of basophilic granulocyte absolute number;Basophil granule is thin
Born of the same parents' percentage 1.12% ↑.
Patient has the phenomenon that exacerbation because voluntarily taking medicine without the state of an illness is improved instead.It can be seen that patient's from audit report
Leucocyte and other index of correlation are obviously higher.Then and start to take a kind of the of research and development of my company and prevent in bronchitis
Medicine preparation, after taking a period of time, the patient feels are good, and cough cough, which is eaten, to be significantly reduced, and asthma symptom uncomfortable in chest disappears, and rechecks result
There is different degrees of improvement and some indexes reach standard with the discovery indices that compare before, entire people is obvious
It is energetic in light state.
Clinical case 12:
Li Honghui, male, 72 years old.Past medical history: patient previously has chronic bronchitis more than 20 years, whenever winter-spring season cough and asthma
It aggravates.Present illness history: patient consciously has a stuffy nose before five days, runny nose cough, dizzy out of strength, and gradually row aggravates the state of an illness, cough and asthma, and phlegm matter is yellow
It is thick, medium, no trace of blood is measured, in the course of disease, no fever, shortness of breath is uncomfortable in chest, palpitaition, receives difference, and pulmonary emphysema sign, symptom is further over 1 day
It aggravates, stool and urine is normal, and weight is without substantially changeing.
2014-06-16 physical examination: alkaline phosphatase 232U/L ↑;Glucose 4.62mmol/L ↓;Immunoglobulin A 8.12g/L
↑;Immunoglobulin G 21.25g/L ↑;Immunoglobulin M 7.82g/L ↑;9.78 μ g/L of cytokeratin 19 fragment ↑;Neuron
27.21 μ g/L of specificity olefinic alcohol enzyme ↑;8.31 μ g/L of phosphorus shape cell cancer associated antigen ↑;24.12 10^9/L of leucocyte;Acidophilus
3.23 10^9/L of property granulocyte absolute number ↑;Eosinophil percentage 14.43% ↑;Basophilic granulocyte absolute number 1.76
10^9/L↑;Basophilic granulocyte percentage 3.24% ↑.
2016-02-18 physical examination: blood routine: hemoglobin 105g/L ↓;Red blood cell be averaged HGB content 24pg ↓;Red blood cell is flat
Equal HGB concentration 281g/L ↓;Erythrocyte volume distribution width 17.1% ↑;Mean platelet volume 0.5% ↑;Average platelet concentration
30g/dL↑;18.04 10^9/L of leucocyte;1.32 10^9/L of eosinophil absolute number ↑;Neuron specific enolase
24.35 μ g/L of enzyme ↑;5.73 μ g/L of phosphorus shape cell cancer associated antigen ↑.
2017-07-13 physical examination: alkaline phosphatase 149U/L ↑;Immunoglobulin A 4.82g/L ↑;Immunoglobulin G
16.47g/L↑;Immunoglobulin M 1.97g/L ↑;8.61 μ g/L of cytokeratin 19 fragment ↑;Neuronspecific enolase
23.65μg/L↑;5.82 μ g/L of phosphorus shape cell cancer associated antigen ↑;17.42 10^9/L of leucocyte;Eosinophil absolute number
0.92 10^9/L↑;Eosinophil percentage 12.25% ↑;1.21 10^9/L of basophilic granulocyte absolute number ↑;Basophil granule
Cell percentages 1.78% ↑.
Patient violates more than 20 years chronic bronchitis, especially aggravates whenever season exchanges the period state of an illness, especially spring and autumn
Time.Then patient starts to take a kind of Chinese materia medica preparation for preventing bronchitis of the research and development of my company in August, 2014, takes
It is checked after a period of time, has different degrees of improvement with the discovery indices that compare before, in July, 2017
When part is checked again, discovery indices tend to designation number, and sufferers themselves also illustrate that nasal obstruction, cough and asthma, shortness of breath, cough
It coughs, is uncomfortable in chest, the fewer and fewer recurrent exerbation of these symptoms, the state of mind such as palpitaition become better and better, and can suitably carry out outdoor fortune
It is dynamic.
Clinical case 13:
Leaf Jinhua, male, 36 years old.Main suit: repeated coughing in recent years, mostly during the cold season, temperature cataclysm when occur, sooner or later
Frequently, daytime mitigates, the sticky phlegm of cough for cough.
2015-03-18 physical examination: alkaline phosphatase 281U/L ↑;Immunoglobulin A 9.86g/L ↑;Immunoglobulin G
26.82g/L↑;Immunoglobulin M 6.63g/L ↑;8.21 μ g/L of cytokeratin 19 fragment ↑;Neuronspecific enolase
26.53μg/L↑;5.28 μ g/L of phosphorus shape cell cancer associated antigen ↑;27.81 10^9/L of leucocyte;Eosinophil absolute number
2.13 10^9/L↑;1.25 10^9/L of basophilic granulocyte absolute number ↑;Basophilic granulocyte percentage 4.15% ↑.
2017-09-28 physical examination: alkaline phosphatase 128U/L ↑;Immunoglobulin A 4.16g/L ↑;Immunoglobulin G
14.05g/L;Immunoglobulin M 2.311g/L;3.46 μ g/L of cytokeratin 19 fragment;Neuronspecific enolase
15.36μg/L;1.18 μ g/L of phosphorus shape cell cancer associated antigen;8.67 10^9/L of leucocyte;RBC mean hemoglobin concentration
352.16g/L↑;Eosinophil percentage 7.75%;Basophilic granulocyte absolute number 0.0610^9/L.
It can be appreciated that patient sees a doctor since uncomfortable, but effect is less obvious from the physical examination of patient report, disease
Feelings do not have much improvement.Then start to take a kind of Chinese medicine system for preventing bronchitis of the research and development of my company in April, 2015
Agent, after taking 2 years, patient during the cold season, temperature cataclysm when cough number greatly reduce, through checking, every index of patient
It improves, and some indexes have reached typical coefficient, the state of mind of entire people is also become better and better, energetic.
Clinical case 14:
Zhao Fugui, male, 38 years old.Main suit: patients bronchial's inflammation has several years, does not just smoke before 10 years.Have two every year
Three times bronchitis coughs are spoken all not all right when serious.
2015-01-16 physical examination: alkaline phosphatase 266U/L ↑;Immunoglobulin A 9.23g/L ↑;Immunoglobulin G
29.72g/L↑;Immunoglobulin M 6.27g/L ↑;9.98 μ g/L of cytokeratin 19 fragment ↑;Neuronspecific enolase
23.36μg/L↑;Phosphorus shape cell cancer antigen 4 .24 μ g/L ↑;21.87 10^9/L of leucocyte;Eosinophil absolute number
2.13 10^9/L↑;1.35 10^9/L of basophilic granulocyte absolute number ↑;Basophilic granulocyte percentage 3.74% ↑.
2017-03-20 physical examination: alkaline phosphatase 152U/L ↑;Immunoglobulin A 3.92g/L ↑;Immunoglobulin G
15.94g/L↑;Immunoglobulin M 2.05g/L;4.32 μ g/L of cytokeratin 19 fragment;Neuronspecific enolase
16.35μg/L↑;1.91 μ g/L of phosphorus shape cell cancer associated antigen ↑;9.38 10^9/L of leucocyte;RBC mean hemoglobin concentration
353.86g/L↑;Eosinophil percentage 7.27%;0.05 10^9/L of basophilic granulocyte absolute number ↑.
It can be appreciated that the leucocyte of patient and other index of correlation are obviously higher from the physical examination of patient report, patient
Speaking when coughing serious all, which could not explain, comes, and then starts a kind of Chinese medicine system for preventing bronchitis for the research and development for taking my company
Agent, after taking 2 years, patient be clearly felt that the symptoms such as the appearance acutely coughed reduce, every time cough when also can normal speech,
The state of mind is also become better and better, energetic.
Clinical case 15:
Wang Min, female, 46 years old.Main suit: it coughs, expectoration is relatively more rapid and recurrent exerbation;It is easy out of breath, spiritlessness and weakness.
Chest auscultation: vesicluar sound enhancing, vesicluar sound weakens when concurrent pulmonary emphysema, can often hear dry rale.Chest percussion pitch is bright, lung
Boundary is loose.X-ray inspection: the bronchus shade of lung increases weight and extends.
2014-05-16 physical examination: alkaline phosphatase 236U/L ↑;Immunoglobulin A 9.32g/L ↑;Immunoglobulin G
28.78g/L↑;Immunoglobulin M 5.24g/L ↑;9.69 μ g/L of cytokeratin 19 fragment ↑;Neuronspecific enolase
21.79μg/L↑;3.71 μ g/L of phosphorus shape cell cancer associated antigen ↑;1.25 10^9/L of basophilic granulocyte absolute number ↑;Basophil granule
Cell percentages 3.37% ↑.
2017-11-08 physical examination: alkaline phosphatase 162U/L ↑;Immunoglobulin A 3.82g/L ↑;Immunoglobulin G
17.01g/L↑;Immunoglobulin M 2.15g/L;4.14 μ g/L of cytokeratin 19 fragment;Neuronspecific enolase
15.35μg/L↑;1.76 μ g/L of phosphorus shape cell cancer associated antigen ↑;9.22 10^9/L of leucocyte;RBC mean hemoglobin concentration
354.06g/L↑;Eosinophil percentage 7.21%;0.06 10^9/L of basophilic granulocyte absolute number ↑.
It can be appreciated that patient violates bronchitis from the physical examination of patient report, therapeutic effect is less obvious.Understanding
To after a kind of Chinese materia medica preparation for preventing bronchitis of the research and development of my company, start to take in conjunction with the practical state of an illness, and in May, 2014
With, after taking a period of time, hospital is gone to be checked, reinspection result with before compare discovery indices it is different
The improvement of degree.Patient also obviously feels that the symptoms such as cough, expectoration appearance are reduced, and breathes also smooth very much, the state of mind
It becomes better and better.
The aforementioned description to specific exemplary embodiment of the invention is in order to illustrate and illustration purpose.These descriptions
It is not wishing to limit the invention to disclosed precise forms, and it will be apparent that according to the above instruction, can much be changed
And variation.The purpose of selecting and describing the exemplary embodiment is that explaining specific principle of the invention and its actually answering
With so that those skilled in the art can be realized and utilize a variety of different exemplary implementation schemes of the invention and
Various chooses and changes.The scope of the present invention is intended to be limited by claims and its equivalents.
Claims (3)
1. a kind of Chinese medicine composition for treating bronchitis, which is characterized in that be made of following raw material according to parts by weight: mulberry fruit
6-11 parts, 1-4 parts of hawthorn, 5-9 parts of gekko, 4-10 parts of campanulaceae, 4-9 parts of radix bupleuri, 3-8 parts of perilla leaf, 5-10 parts of loquat seed, red scape
Its 3-11 parts, 2-6 parts of teasel root, 5-11 parts of lalang grass rhizome, 4-11 parts of semen armeniacae amarae, 5-12 parts of Radix Glycyrrhizae, 3-9 parts of cordate houttuynia, hairyvein agrimony 3-8
It is part, 2-8 parts of Herba Lycopodii, 4-9 parts of bulbus fritillariae cirrhosae, 5-11 parts of herba lysimachiae, 2-6 parts of peach kernel, 5-10 parts of rabdosia lophanthide, 3-9 parts of rhizoma arisaematis, white
5-11 parts of the root of Dahurian angelica, 3-8 parts of oyster, 3-9 parts of the seed of Oriental arborvitae, 3-7 parts of peppermint, 3-8 parts of Radix Salviae Miltiorrhizae, 4-10 parts of Radix Codonopsis, 3-6 parts of sea-buckthorn, ox lung
2-5 parts, 1-3 parts of Asian puccoon, 0.1-0.5 parts of madder, 1-4 parts of pheretima, 1-5 parts of cicada slough, 3-10 parts of Bulbus Allii Fistulosi, 1-5 parts of alpine gentian herb and
2-10 parts of acaulescent pegaeophyton herb.
2. it is according to claim 1 treatment bronchitis Chinese medicine composition, which is characterized in that according to parts by weight by with
Lower raw material composition: 8 parts of mulberry fruit, 2 parts of hawthorn, 6 parts of gekko, 6 parts of campanulaceae, 6 parts of radix bupleuri, 5 parts of perilla leaf, 7 parts of loquat seed, root of kirilow rhodiola
5 parts, 4 parts of teasel root, 6 parts of lalang grass rhizome, 7 parts of semen armeniacae amarae, 8 parts of Radix Glycyrrhizae, 6 parts of cordate houttuynia, 5 parts of hairyvein agrimony, 4 parts of Herba Lycopodii, bulbus fritillariae cirrhosae 5
Part, 7 parts of herba lysimachiae, 4 parts of peach kernel, 7 parts of rabdosia lophanthide, 5 parts of rhizoma arisaematis, 7 parts of the root of Dahurain angelica, 5 parts of oyster, 6 parts of the seed of Oriental arborvitae, 5 parts of peppermint, pellet
Join 5 parts, 6 parts of Radix Codonopsis, 4 parts of sea-buckthorn, 4 parts of ox lung, 2 parts of Asian puccoon, 0.3 part of madder, 2 parts of pheretima, 3 parts of cicada slough, 5 parts of Bulbus Allii Fistulosi, white flower
3 parts and 4 parts of acaulescent pegaeophyton herb of rough gentian.
3. it is according to claim 1 treatment bronchitis Chinese medicine composition, which is characterized in that according to parts by weight by with
Lower raw material composition: 10 parts of mulberry fruit, 3 parts of hawthorn, 8 parts of gekko, 8 parts of campanulaceae, 7 parts of radix bupleuri, 6 parts of perilla leaf, 7 parts of loquat seed, red scape
It 9 parts, 5 parts of teasel root, 8 parts of lalang grass rhizome, 10 parts of semen armeniacae amarae, 10 parts of Radix Glycyrrhizae, 7 parts of cordate houttuynia, 6 parts of hairyvein agrimony, 4 parts of Herba Lycopodii, tendril-leaved fritillary bulb
Female 7 parts, 7 parts of herba lysimachiae, 5 parts of peach kernel, 8 parts of rabdosia lophanthide, 6 parts of rhizoma arisaematis, 8 parts of the root of Dahurain angelica, 5 parts of oyster, 6 parts of the seed of Oriental arborvitae, peppermint 5
Part, 6 parts of Radix Salviae Miltiorrhizae, 8 parts of Radix Codonopsis, 5 parts of sea-buckthorn, 4 parts of ox lung, 2 parts of Asian puccoon, 0.4 part of madder, 3 parts of pheretima, 4 parts of cicada slough, 8 parts of Bulbus Allii Fistulosi,
3 parts and 8 parts of acaulescent pegaeophyton herb of alpine gentian herb.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811097733.6A CN109010639A (en) | 2018-09-20 | 2018-09-20 | A kind of Chinese medicine composition for treating bronchitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811097733.6A CN109010639A (en) | 2018-09-20 | 2018-09-20 | A kind of Chinese medicine composition for treating bronchitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109010639A true CN109010639A (en) | 2018-12-18 |
Family
ID=64617025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811097733.6A Pending CN109010639A (en) | 2018-09-20 | 2018-09-20 | A kind of Chinese medicine composition for treating bronchitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109010639A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102743604A (en) * | 2011-04-21 | 2012-10-24 | 王启凌 | Medicine for treating bronchitis |
-
2018
- 2018-09-20 CN CN201811097733.6A patent/CN109010639A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102743604A (en) * | 2011-04-21 | 2012-10-24 | 王启凌 | Medicine for treating bronchitis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101474377B (en) | Chinese medicine prescription for treating chronic bronchitis | |
CN104225404B (en) | A kind of pharmaceutical composition and its preparation for treating pulmonary fibrosis | |
CN107638507A (en) | A kind of throat-clearing throat-moistening composition and its preparation | |
CN109010639A (en) | A kind of Chinese medicine composition for treating bronchitis | |
CN104623555A (en) | Traditional Chinese medicine preparation for treating acute asthmatic bronchitis and preparation method thereof | |
CN104721573A (en) | Traditional Chinese medicinal composition for treating phlegm-damp type chronic bronchitis | |
CN104958395A (en) | Traditional Chinese medicine composition for treating cold-with-dampness type cough | |
CN109223962A (en) | It is a kind of for treating the Traditional Chinese medicine compound composition and preparation method thereof of pneumoconiosis and pulmonary fibrosis | |
CN109939147A (en) | A kind of Chinese medicine composition that treating acute and chronic pharyngitis, preparation and its application | |
CN104173716A (en) | Traditional Chinese medicine decoction treating acute and chronic pharyngitis | |
CN107441322A (en) | It is a kind of to be used to treat pill medicine of cough and preparation method thereof | |
CN103212005B (en) | Traditional Chinese medicine composition for treatment of wind-dryness cough | |
CN101537163A (en) | Chinese traditional medicine composition for curing emphysema and preparation method thereof | |
CN104983799A (en) | Traditional Chinese medicine composition for treating pulmonary abscess in abscess formation stage | |
CN1895536A (en) | Chinese-medicinal preparation for treating emphysema and tracheitis | |
CN108208801A (en) | Prevent the food of bronchitis | |
CN105726841A (en) | Drug for treating chronic bronchitis | |
CN105327321A (en) | Periostracum cicada combinational medicine for treating asthma in elderly | |
CN103860936A (en) | Chinese medicine composition for treating bronchial asthma caused by syndrome of cold fluid retained in lung | |
CN105396071A (en) | Traditional Chinese medicine formula for treating children pneumonia | |
CN108743856A (en) | A kind of Chinese medicine composition that treating bronchitis and its application | |
CN109394862A (en) | A kind of Chinese medicine composition and preparation method thereof for treating bronchial asthma | |
CN104983882A (en) | Traditional Chinese medicine composition for treating obstructive sleep apnea and hypoventilation syndrome | |
CN103977136A (en) | Chinese medicinal composition for treating bronchial asthma of phlegm stagnation and qi obstruction symptom | |
CN104274702A (en) | Traditional Chinese medicine preparation for treating chronic cardiac-failure qi deficiency and blood stasis and syndrome of internal stagnation of fluid-dampness |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181218 |